Have Insiders Sold Medpace Holdings Shares Recently?
Some Medpace Holdings, Inc. (NASDAQ:MEDP) shareholders may be a little concerned to see that the CEO, President & Chairman, August Troendle, recently sold a substantial US$44m worth of stock at a price of US$627 per share. However, it's crucial to note that they remain very much invested in the stock and that sale only reduced their holding by 1.4%.
Medpace Holdings Insider Transactions Over The Last Year
Notably, that recent sale by CEO, President & Chairman August Troendle was not the only time they sold Medpace Holdings shares this year. They previously made an even bigger sale of -US$62m worth of shares at a price of US$616 per share. So it's clear an insider wanted to take some cash off the table, even slightly below the current price of US$617. When an insider sells below the current price, it suggests that they considered that lower price to be fair. That makes us wonder what they think of the (higher) recent valuation. However, while insider selling is sometimes discouraging, it's only a weak signal. This single sale was just 1.8% of August Troendle's stake.
Medpace Holdings insiders didn't buy any shares over the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
See our latest analysis for Medpace Holdings
If you are like me, then you will not want to miss this free list of small cap stocks that are not only being bought by insiders but also have attractive valuations.
Insider Ownership Of Medpace Holdings
Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. A high insider ownership often makes company leadership more mindful of shareholder interests. Medpace Holdings insiders own 19% of the company, currently worth about US$3.4b based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.
What Might The Insider Transactions At Medpace Holdings Tell Us?
Insiders haven't bought Medpace Holdings stock in the last three months, but there was some selling. And there weren't any purchases to give us comfort, over the last year. But it is good to see that Medpace Holdings is growing earnings. While insiders do own a lot of shares in the company (which is good), our analysis of their transactions doesn't make us feel confident about the company. While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. At Simply Wall St, we found 1 warning sign for Medpace Holdings that deserve your attention before buying any shares.
Of course Medpace Holdings may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.